Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins

Autor: Carine Derviaux, Stefan Knapp, Yuliia V. Voitovich, Brigitt Raux, Stéphane Priet, Jean Michel Brunel, Yves Collette, Sabine Milhas, Stephane Betzi, Eric Trinquet, Alexey Yu. Fedorov, Philippe Roche, Thomas Roux, Etienne Rebuffet, Adrien Lugari, Sebastien Combes, Jean-Claude Guillemot, Xavier Morelli
Přispěvatelé: Architecture et fonction des macromolécules biologiques (AFMB), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2016, 59 (4, SI), pp.1634-1641. ⟨10.1021/acs.jmedchem.5b01708⟩
Journal of Medicinal Chemistry, 2016, 59 (4, SI), pp.1634-1641. ⟨10.1021/acs.jmedchem.5b01708⟩
ISSN: 0022-2623
1520-4804
DOI: 10.1021/acs.jmedchem.5b01708⟩
Popis: A midthroughput screening follow-up program targeting the first bromodomain of the human BRD4 protein, BRD4(BD1), identified an acetylated-mimic xanthine derivative inhibitor. This compound binds with an affinity in the low micromolar range yet exerts suitable unexpected selectivity in vitro against the other members of the bromodomain and extra-terminal domain (BET) family. A structure-based program pinpointed a role of the ZA loop, paving the way for the development of potent and selective BET-BRDi probes.
Databáze: OpenAIRE